Petros Pharmaceuticals to Present at the Q4 Investor Summit Conference

Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeutics for men’s health, announces today that President and Chief Commercial Officer Fady Boctor will present a corporate overview at the Q4 Investor Summit Conference, which is being held virtually on November 16 – 17, 2021.

NEW YORK, Nov. 11, 2021 /PRNewswire/ -- Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeutics for men’s health, announces today that President and Chief Commercial Officer Fady Boctor will present a corporate overview at the Q4 Investor Summit Conference, which is being held virtually on November 16 – 17, 2021.

Mr. Boctor will deliver his corporate presentation on Wednesday, November 17 at 1:15 PM ET.

Mr. Boctor will be available for one-on-one meetings throughout the conference.

Register HERE to watch the presentation.

About Petros Pharmaceuticals
Petros Pharmaceuticals is committed to the goal of becoming a world-leading specialized men’s health company by identifying, developing, acquiring, and commercializing innovative therapeutics for men’s health issues including, but not limited to erectile dysfunction, endothelial dysfunction, psychosexual and psychosocial ailments, Peyronie’s disease, hormone health and substance use disorders.

Cision View original content:https://www.prnewswire.com/news-releases/petros-pharmaceuticals-to-present-at-the-q4-investor-summit-conference-301422083.html

SOURCE Petros Pharmaceuticals, Inc.


Company Codes: NASDAQ-NMS:PTPI
MORE ON THIS TOPIC